Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

BACKGROUND: GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Masatoshi, Ikeda, Masafumi, Takayama, Tadatoshi, Numata, Kazushi, Izumi, Namiki, Furuse, Junji, Okusaka, Takuji, Kadoya, Masumi, Yamashita, Satoshi, Ito, Yuichiro, Kokudo, Norihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121182/
https://www.ncbi.nlm.nih.gov/pubmed/27106231
http://dx.doi.org/10.1007/s00535-016-1204-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121182/
https://www.ncbi.nlm.nih.gov/pubmed/27106231
http://dx.doi.org/10.1007/s00535-016-1204-2

Ejemplares similares